CN108779157B - 新α-1-微球蛋白衍生蛋白及其应用 - Google Patents

新α-1-微球蛋白衍生蛋白及其应用 Download PDF

Info

Publication number
CN108779157B
CN108779157B CN201780018244.4A CN201780018244A CN108779157B CN 108779157 B CN108779157 B CN 108779157B CN 201780018244 A CN201780018244 A CN 201780018244A CN 108779157 B CN108779157 B CN 108779157B
Authority
CN
China
Prior art keywords
glu
thr
gly
lys
asp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201780018244.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN108779157A (zh
Inventor
勒纳·韦斯特·罗森洛夫
安纳莉·爱德斯特罗姆·黑格尔瓦尔
布·阿克尔斯特罗姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guardian Medical International
Guard Therapeutics International AB
Original Assignee
Guardian Medical International
A1M Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guardian Medical International, A1M Pharma AB filed Critical Guardian Medical International
Publication of CN108779157A publication Critical patent/CN108779157A/zh
Application granted granted Critical
Publication of CN108779157B publication Critical patent/CN108779157B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
CN201780018244.4A 2016-03-18 2017-03-17 新α-1-微球蛋白衍生蛋白及其应用 Active CN108779157B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201670158 2016-03-18
DKPA201670158 2016-03-18
PCT/EP2017/056436 WO2017158181A1 (en) 2016-03-18 2017-03-17 Novel alpha-1-microglobulin derived proteins and their use

Publications (2)

Publication Number Publication Date
CN108779157A CN108779157A (zh) 2018-11-09
CN108779157B true CN108779157B (zh) 2022-12-30

Family

ID=56080208

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780018244.4A Active CN108779157B (zh) 2016-03-18 2017-03-17 新α-1-微球蛋白衍生蛋白及其应用

Country Status (14)

Country Link
US (1) US10981963B2 (enExample)
EP (1) EP3430032B1 (enExample)
JP (1) JP6976579B2 (enExample)
KR (1) KR102437662B1 (enExample)
CN (1) CN108779157B (enExample)
AU (1) AU2017235608B2 (enExample)
CA (1) CA3017836A1 (enExample)
EA (1) EA039776B1 (enExample)
ES (1) ES2896734T3 (enExample)
MX (1) MX2018011193A (enExample)
NZ (1) NZ746677A (enExample)
SG (1) SG11201807352XA (enExample)
WO (1) WO2017158181A1 (enExample)
ZA (1) ZA201805797B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3703729A1 (en) * 2017-11-03 2020-09-09 Guard Therapeutics International AB Use of alpha-1-microglobulin for protection of bone marrow cells
AU2024219294A1 (en) 2023-02-08 2025-07-10 Guard Therapeutics International AB Alpha-1-microglobulin derived peptide fragments and uses thereof
US12227343B2 (en) * 2023-03-17 2025-02-18 Blue Buffalo Enterpises, Inc. Retail ready opening feature for e-commerce carton

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010006809A2 (en) * 2008-07-18 2010-01-21 Akerstroem Bo Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
WO2014047490A1 (en) * 2012-09-21 2014-03-27 Beintoo, S.P.A. Interactive experience fully contained within an expandalble embedded unit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9758554B2 (en) * 2012-01-31 2017-09-12 Technische Universitaet Muenchen Muteins of α1m lipocalin and method of production therefor
PL2900254T3 (pl) * 2012-09-05 2017-02-28 A1M Pharma Ab Alfa-1 mikroglobulina do użycia w leczeniu chorób związanych z mitochondriami
US10226570B2 (en) * 2017-03-10 2019-03-12 Seton Healthcare Family Apparatus and method for temporarily securing a movable accessory device relative to a movable patient

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010006809A2 (en) * 2008-07-18 2010-01-21 Akerstroem Bo Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
WO2014047490A1 (en) * 2012-09-21 2014-03-27 Beintoo, S.P.A. Interactive experience fully contained within an expandalble embedded unit

Also Published As

Publication number Publication date
BR112018068522A2 (pt) 2019-01-22
US10981963B2 (en) 2021-04-20
WO2017158181A1 (en) 2017-09-21
EA039776B1 (ru) 2022-03-11
EA201892085A1 (ru) 2019-02-28
CA3017836A1 (en) 2017-09-21
MX2018011193A (es) 2019-03-28
CN108779157A (zh) 2018-11-09
ZA201805797B (en) 2022-03-30
ES2896734T3 (es) 2022-02-25
KR102437662B1 (ko) 2022-08-29
KR20180127411A (ko) 2018-11-28
NZ746677A (en) 2023-02-24
US20190161524A1 (en) 2019-05-30
SG11201807352XA (en) 2018-09-27
EP3430032A1 (en) 2019-01-23
EP3430032B1 (en) 2021-09-01
AU2017235608B2 (en) 2020-10-22
JP2019519466A (ja) 2019-07-11
JP6976579B2 (ja) 2021-12-08
AU2017235608A1 (en) 2018-10-18

Similar Documents

Publication Publication Date Title
Ishikawa et al. A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis
US20220370560A1 (en) Ptd-smad7 therapeutics
DK2900254T3 (en) ALFA-1 MICROGLOBULIN TO USE IN THE TREATMENT OF MITOCONDRY-RELATED DISEASES
JP2003515338A (ja) 補体結合酵素、ｍａｓｐ−３、及びその使用
CN108779157A (zh) 新α-1-微球蛋白衍生蛋白及其应用
Yang et al. Decorin is a Zn2+ metalloprotein
KR20130132375A (ko) 신장 증후군 및 관련 질환을 치료하는 방법
CN100537602C (zh) Ec sod和细胞转导性ec sod及它们的用途
AU2003234066B2 (en) Muteins of placental growth factor type 1, preparation method and application thereof
KR20150140686A (ko) 신증후군 및 관련 병태의 치료 방법
JP2006515168A (ja) 細胞におけるペルオキシソームカタラーゼ機能の促進
JP2006515168A5 (enExample)
CN120712100A (zh) α-1-微球蛋白衍生的肽片段及其用途
WO2025172720A1 (en) Fragment of complement factor h related protein 5 which restores complement regulation
EP2404613B1 (en) Novel uses of fibrinogen-420 and active domain thereof
CN116635528A (zh) 补体因子i相关组合物和方法
Ahmed Investigation into the Structure and Function of Hsp47

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: Lund, Sweden

Applicant after: Guardian Medical International

Address before: Lund, Sweden

Applicant before: A1M PHARMA AB

CB02 Change of applicant information
CB02 Change of applicant information

Address after: Stockholm, SWE

Applicant after: Guardian Medical International

Address before: Longde, Sweden

Applicant before: Guardian Medical International

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant